STRATEGIC INTELLIGENCE BRIEFING
TO: CourMed Board of Directors, Executive Committee & Institutional Partners
Subject: Bridging the $350B Execution Gap via The Private Health Office
Author: Derrick L. Miles, FACHE | Chairman, CourMed® | The Private Health Office
Distribution: Single-Family Offices (SFOs), Wealth Stewardship Boards, UHNW Trustees, Luxury Residential Developers & Owners
Executive Summary: The Execution Friction Conundrum
When Boston Consulting Group (BCG) constructed CourMed’s initial Go-To-Market architecture in December 2022, our core premise was clear: ultra-high-net-worth (UHNW) principals do not suffer from a lack of access to elite medicine—they suffer from a lack of integrated execution inside their private daily lives.
BCG’s latest publication, The Longevity Review 2026 (co-authored with the Super Human Network), validates the exact structural bottleneck we identified four years ago. Despite unprecedented capital deployment into longevity protocols, advanced diagnostics, and gerotherapeutic therapies, the broader market remains paralyzed by an operational disconnect. While the market is flooded with fragmented clinical options, it severely lacks the non-clinical operational infrastructure required to deliver continuous, 365-day execution across private estates.
Macro Market Analysis vs. Sovereign Execution
1. Capturing the $350B Execution Gap
-
BCG 2026 Market Insight: BCG’s global data (n=9,350) reveals that despite massive public discourse and investment, active engagement with healthy aging protocols drops dramatically due to execution friction. BCG explicitly highlights that the core constraint facing the market is no longer scientific discovery, but the absence of a delivery and implementation model capable of translating complex science into daily life.
-
CourMed Operational Solution: To solve this $350B execution gap, CourMed® does not compete with external physicians, diagnostic nodes, or culinary specialists. We own and operate The Private Health Office—the sovereign access highway, Agentic AI telemetry (The Oracle), and gatekeeper infrastructure that governs how health and vitality protocols cross the estate perimeter.
2. Protecting Multi-Generational Capital & Key-Person Risk
-
BCG 2026 Market Insight: The report notes that extending healthy life expectancy by just one year carries an estimated $38 Trillion in aggregate economic value, proving that healthspan optimization is fundamentally an institutional risk-management issue.
-
CourMed Operational Solution: For Single-Family Offices (SFOs) and trustees, biological disruption in a primary principal represents an unhedged Key-Person Risk. CourMed translates health tracking into an institutional risk mitigation utility, protecting multi-generational asset continuity without forcing the family office to manage clinical operations.
3. Sovereign Developer Integration
-
BCG 2026 Market Insight: While cumulative sector funding has surpassed $21 Billion, physical longevity centers face immense real estate drag, high capital expenditures, and liability constraints.
-
CourMed Operational Solution: Master-developers of premier luxury residential compounds (e.g., EDITION, St. Regis, Faena House Residences Miami Beach) cannot surrender prime residential square footage or accept HOA clinical exposure. CourMed’s Zero CAPEX, Zero Square Footage Surrendered, Zero Medical Liability model provides a seamless health security utility layer while preserving 100% of saleable penthouse yield.